novo nordisk reuters - Search News

News

Novo Nordisk Shares Plummet

Reuters on MSN · 3h

Novo Nordisk slides further on US competition, new CEO concerns

Shares in Wegovy maker Novo Nordisk fell further on Wednesday as analysts warned of persistent competition from copycat drugs in the United States, a day after a profit warning and the naming of a new CEO prompted investors to wipe $70 billion off the drugmaker's value.

Bloomberg on MSN · 1d

Novo Falls by Record as Wegovy Slumps and Insider Named CEO

Novo Nordisk A/S named its head of international operations as chief executive officer after slumping weight-loss drug sales led to a profit warning that wiped $93 billion off its market value.

Wall Street Journal · 1d

Novo Nordisk Shares Plummet as Competition Weighs on Sales

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

Novo, Wegovy maker

Reuters on MSN · 22h

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in the obesity drug market.

Hosted on MSN · 1d

Europe shares dented as Novo warning burns $92 billion in market cap

European shares turned lower on Tuesday after a shock profit warning from Novo Nordisk wiped more than 80 billion euros ($92.34 billion) off the heavyweight drugmaker's market value at one point. Europe's region-wide STOXX 600 index took a hit,

New York Post on MSN · 20h

Wegovy maker Novo’s profit warning wipes out $70B in market value after shares plunge 30%

Investors wiped $70 billion off Novo Nordisk’s market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in the obesity drug market.

18h

Obesity Drugmaker Novo Nordisk Plunges as It Cuts Forecasts Again

Novo now expects 2025 sales growth of 8%-14% in local currencies, down from its previous 13-21% range. It also lowered its ...

1don MSN

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results